Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The vaginal extracellular matrix (ECM) is a dynamic and complex network of macromolecules, including collagen, elastin, and proteoglycans, that provides essential structural support and mechanical properties to the vaginal wall (National Institutes of Health, 2023). It plays a critical role in maintaining tissue elasticity and tensile strength, which are vital for normal pelvic floor function and reproductive health (PubMed, PMID: 15749514). Pathological remodeling of the vaginal ECM, often involving an imbalance between matrix synthesis and degradation by matrix metalloproteinases (MMPs), is a hallmark of conditions such as pelvic organ prolapse and vaginal atrophy (PubMed, PMID: 22403107). Therapeutic interventions often target the ECM by utilizing estrogens or selective estrogen receptor modulators (SERMs) to stimulate the production of collagen and elastin, thereby restoring tissue integrity (PubMed, PMID: 28813331). Additionally, regenerative medicine approaches focus on using decellularized vaginal ECM or synthetic scaffolds to promote tissue repair and functional recovery in patients with pelvic floor disorders (PubMed, PMID: 30145564).
Activation of estrogen receptors to stimulate collagen and elastin synthesis; inhibition of matrix metalloproteinases to reduce ECM degradation; physical supplementation of the matrix to improve hydration and volume.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Vaginal extracellular matrix (Vaginal ECM) (Vaginal ECM).